All sponsors

PT. Prodia Stem Cell Indonesia

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS8
PHASE 3 / 2-31
RECRUITING3
READOUTS ≤12 MONTHS4
READOUT SLIPPED >6 MO100%

Delay Index: of 5 active trials registered more than a year ago, 5 have moved their primary completion (readout) date by more than 6 months since first registration (median +51.0 months). See all sponsors →

Open PT. Prodia Stem Cell Indonesia on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Auto-DC (Autologous Dendritic Cell as Adjuvant Therapy)
NCT05261750
P1/2Active, not recruitingNasopharyngeal Cancer152026-02-28 (+47 mo)
Conditioned Medium
NCT05008588
P1/2Active, not recruitingIschemic Stroke152026-03 (+51 mo)
Secretome
NCT07429253
P1/2RecruitingAndrogenetic Alopecia402026-06-30
Umbilical Cord Mesenchymal Stem Cells
NCT04314687
P1/2Active, not recruitingCerebral Palsy782026-07 (+72 mo)
Control (NaCl 0.9%)
NCT07439848
P1/2RecruitingAcute Respiratory Distress Syndrome152026-12
Allogeneic Umbilical Cord Mesenchymal Stem Cell
NCT04357600
P1/2Enrolling by invitationLiver Cirrhoses122027-06-20 (+78 mo)
Umbilical Cord Mesenchymal Stem Cells
NCT07396155
P1/2RecruitingDiabetic Nephropathy Type 2102027-07
1.5 x 10^6 UC-MSC + CM
NCT05909488
P2/3Not yet recruitingRetinitis Pigmentosa302027-07 (+19 mo)